DoD Neurofibromatosis New Investigator Award | W81XWH 18 NFRP NIA

Opportunity Information: Apply for W81XWH 18 NFRP NIA

The DoD Neurofibromatosis New Investigator Award is a Department of Defense research funding opportunity designed to bring new talent into neurofibromatosis (NF) research and to help early-stage independent researchers build a stable trajectory in this field. Its central purpose is career development through research support: it aims to nurture promising investigators who are beginning to establish independence, as well as to encourage established scientists from other disciplines to pivot their expertise toward NF-related questions. A key point is that applicants do not need prior NF experience to be competitive, but applicants who have limited NF background are strongly encouraged to include a collaborator with demonstrated NF expertise, which signals that the program values both fresh perspectives and credible disease-area guidance.

Administratively, the opportunity is titled "DoD Neurofibromatosis New Investigator Award" and was released under Funding Opportunity Number W81XWH 18 NFRP NIA. It falls under a discretionary funding category and supports science and technology and other research and development activities. Awards may be issued as either grants or cooperative agreements, meaning that depending on the mechanism, the government may simply fund the work (grant) or may also have a more active role in overseeing and coordinating aspects of the project (cooperative agreement). The listing is associated with CFDA number 12.420, which is commonly used for military medical research and development programs.

Eligibility is broadly open, described as "unrestricted," which generally means that many types of organizations and entities can apply, subject to any additional eligibility clarifications contained in the full announcement text. The sponsoring agency is the Department of Defense, specifically the Department of the Army through the U.S. Army Medical Research Acquisition Activity (USAMRAA), the office that commonly administers and manages these medical research funding opportunities.

In terms of timing and scale, the opportunity was created on May 14, 2018, with an original application deadline of August 9, 2018. The notice anticipated making about three awards. The "award ceiling" is listed as 0 in the summary data, which typically indicates that a maximum dollar amount was not captured in the abbreviated record or that applicants needed to refer to the full funding announcement for budget limits and constraints rather than relying on the database summary.

Overall, the program is best understood as an entry and transition mechanism for NF research: it lowers the barrier for scientists who have strong ideas and relevant technical skills but may not yet have an NF track record, while still encouraging mentorship or collaboration to ensure disease-area rigor. This structure supports both workforce development in NF research and the infusion of new methods and perspectives from adjacent fields.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Neurofibromatosis New Investigator Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on May 14, 2018.
• Applicants must submit their applications by Aug 09, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 3 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 18 NFRP NIA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: